216 related articles for article (PubMed ID: 37072468)
21. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
22. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
[TBL] [Abstract][Full Text] [Related]
23. [A practical guide to chronic inflammatory bowel disease].
Salvador Nunes L; Greuter T; Henchoz S; Schoepfer A
Rev Med Suisse; 2021 Sep; 17(748):1448-1452. PubMed ID: 34468095
[TBL] [Abstract][Full Text] [Related]
24. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
26. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
[TBL] [Abstract][Full Text] [Related]
27. Ulcerative colitis or Crohn's disease? Pitfalls and problems.
Feakins RM
Histopathology; 2014 Feb; 64(3):317-35. PubMed ID: 24266813
[TBL] [Abstract][Full Text] [Related]
28. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
[TBL] [Abstract][Full Text] [Related]
29. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
30. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Vosoghinia H; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Rayatpisheh M; Sima AR; Malekzadeh R
Inflamm Bowel Dis; 2022 Jul; 28(7):1004-1011. PubMed ID: 34417824
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
[TBL] [Abstract][Full Text] [Related]
32. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
33. Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.
King D; Chandan JS; Thomas T; Denniston AK; Braithwaite T; Niranthrankumar K; Reulen R; Adderley N; Trudgill NJ
BMJ Open; 2022 May; 12(5):e052833. PubMed ID: 35545379
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.
Sipos F; Galamb O; Wichmann B; Krenács T; Tóth K; Leiszter K; Muzes G; Zágoni T; Tulassay Z; Molnár B
Dis Markers; 2011; 30(1):1-17. PubMed ID: 21508504
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
37. Perceptive eating as part of the journey in inflammatory bowel disease: Lessons learned from lived experience.
Nowlin S; Manning L; Keefer L; Gorbenko K
Clin Nutr ESPEN; 2021 Feb; 41():299-304. PubMed ID: 33487280
[TBL] [Abstract][Full Text] [Related]
38. Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies.
Paridhi ; Singh K; Kumar V; Tewari S; Misra V; Misra SP; Dwivedi M
Indian J Pathol Microbiol; 2022; 65(3):558-564. PubMed ID: 35900482
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
40. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
